Monvia Limited reported a $28.7 million revenue year with a $6.9 million adjusted EBITDA, exceeding IPO forecasts, while renewing a $60 million contract with MetLife and completing its ASX listing.
- FY26 revenue of $28.7 million
- Adjusted EBITDA of $6.9 million surpasses IPO forecast
- Five-year $60 million contract renewal with MetLife
- ASX listing completed with $17.5 million raised
- Annual Recurring Revenue grows 21% to $14 million
Financial performance exceeds expectations amid major milestones
Monvia Limited (ASX:MNV) closed FY26 with a robust $28.7 million revenue haul and an adjusted EBITDA of $6.9 million, comfortably ahead of its IPO prospectus forecast of $6.6 million. Despite a statutory net loss of $13.5 million, largely attributed to one-off IPO and acquisition costs plus non-cash fair value adjustments on preference shares, the underlying business performance signals a strong operating foundation.
The company’s Annual Recurring Revenue (ARR) hit $14 million as of 1 July 2026, marking a 21% year-on-year increase and now representing half of adjusted revenue. This growth underscores the increasing quality and predictability of Monvia’s revenue streams, driven by solid client retention and expansion.
Strategic contract renewal and acquisition underpin market position
A highlight of the year was the renewal of a significant five-year cornerstone contract with MetLife, valued at approximately $60 million. This deal, which accounts for about 72% of FY26 revenue, reinforces Monvia’s role as a trusted partner in the life insurance technology sector. The renewal comes amid a broader industry push towards modernising legacy systems and adopting cloud-native platforms.
FY26 also saw Monvia complete the acquisition of Monvia Australia Pty Ltd on 1 July 2025, consolidating its operating business under a unified platform. This acquisition was integral to Monvia’s strategy to establish a specialised cloud-based SaaS solution tailored for life insurers, enabling end-to-end policy administration, claims management, and digital integration.
Successful IPO strengthens balance sheet and capital structure
Monvia’s transition to a publicly listed company was finalised on 24 July 2026, raising $17.5 million through an initial public offering at $1.10 per share. This capital injection facilitated the redemption of $12.5 million in Series B Preference Shares and the conversion of $50 million Series A Preference Shares into ordinary shares, significantly improving the company’s net asset position and reducing financial liabilities.
The IPO also enhanced Monvia’s cash position, with pro forma cash of $11.1 million and pro forma debt of $6 million post-listing. This improved financial footing positions Monvia to pursue its growth ambitions with greater flexibility.
Product innovation and growth strategy driving momentum
Monvia continued to invest heavily in its product development, completing five major platform releases during FY26. Notably, the launch of an AI Claims Summarisation tool aims to streamline claims processing, delivering faster and more consistent outcomes for insurers.
The company’s growth strategy focuses on expanding recurring revenue, deepening customer relationships, and leveraging strategic partnerships, including plans to build alliances with Global Systems Integrators to broaden market reach. Geographic expansion into New Zealand and Southeast Asia is also on the horizon, supported by a maturing sales pipeline and increasing market interest in cloud-native insurance platforms.
People and culture underpin sustainable growth
Monvia employs 107 staff across Australia, New Zealand, and the Philippines, with 6.5% of the workforce offshore, reflecting a deliberate move to build offshore capability. The company boasts a strong retention rate of 98% and maintains a balanced gender representation of 43% female employees, underscoring its commitment to building a diverse and high-performing organisation.
Leadership depth and capability development remain strategic priorities for FY27, alongside maintaining a culture that fosters learning and excellence.
Risks and outlook
Monvia’s concentrated revenue base, with MetLife contributing over 70%, poses a client concentration risk, although the recent contract renewal mitigates immediate concerns. The company also faces competitive pressures in a rapidly evolving technology landscape, necessitating ongoing investment in product innovation and cybersecurity.
Looking ahead, Monvia aims to prioritise ARR growth, diversify its client base, and accelerate sales cycles through strategic partnerships. While economic and market dynamics remain uncertain, Monvia’s cloud-native platform and industry expertise position it well to capitalise on the accelerating technology modernisation within the life insurance sector.
Investors should watch how Monvia executes on its international expansion plans and manages client concentration risks as it scales.
Bottom Line?
Monvia’s FY26 results validate its cloud-native life insurance platform strategy, but its heavy reliance on MetLife and ongoing investment needs warrant close attention as it scales.
Questions in the middle?
- How will Monvia diversify its revenue beyond MetLife to reduce client concentration risk?
- Can Monvia sustain its ARR growth while managing the costs of product innovation and geographic expansion?
- What impact will emerging AI and cloud technologies have on Monvia’s competitive positioning in life insurance software?